These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2884187)

  • 1. The clinical significance of intrinsic sympathomimetic activity.
    Northcote RJ
    Int J Cardiol; 1987 May; 15(2):133-50. PubMed ID: 2884187
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intrinsic sympathomimetic activity with beta-receptor blockers. Significance for differential therapy (author's transl)].
    Noack E
    MMW Munch Med Wochenschr; 1982 Apr; 124(15):377-80. PubMed ID: 6123078
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of cardioselectivity and intrinsic sympathomimetic activity in beta-blocking drugs in cardiovascular disease.
    Taylor SH
    Am J Cardiol; 1987 May; 59(13):18F-20F. PubMed ID: 2883872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basis for cardiovascular therapy with beta-blocking agents.
    Opie LH
    Am J Cardiol; 1983 Nov; 52(9):2D-9D. PubMed ID: 6139010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intrinsic sympathomimetic activity of adrenergic beta receptor blockaders and its role in various clinical situations].
    Bubiński R
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1713-6. PubMed ID: 6151656
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical pharmacology of beta-receptor-blocking drugs.
    Dollery CT; Paterson JW; Conolly ME
    Clin Pharmacol Ther; 1969; 10(6):765-99. PubMed ID: 4393717
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs.
    Dollery CT; Paterson JW; Conolly ME
    Clin Pharmacol Ther; 1969; 10(6):765-99. PubMed ID: 4390767
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta 1-adrenoceptor selectivity and intrinsic sympathomimetic activity.
    De Bono GG
    Br J Clin Pharmacol; 1985 Jul; 20(1):92. PubMed ID: 2862899
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical significance of beta 1-selectivity and intrinsic sympathomimetic activity in a beta-adrenergic blocking drug.
    Frishman WH
    Am J Cardiol; 1987 May; 59(13):33F-37F. PubMed ID: 2883876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pharmacology of drugs used for the treatment of cardiovascular disorders].
    Klaus W
    Klin Anasthesiol Intensivther; 1976 Apr; (11):106-22. PubMed ID: 11364
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity on local wall motion abnormalities in patients with coronary heart disease.
    Gleichmann U; Fassbender D; Trieb G; Mannebach H; Ohlmeier H
    Br J Clin Pharmacol; 1982; 13(Suppl 2):301S-304S. PubMed ID: 6125180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of beta 1 selectivity and intrinsic sympathomimetic activity on potential unwanted noncardiovascular effects of beta blockers.
    Kendall MJ
    Am J Cardiol; 1987 May; 59(13):44F-47F. PubMed ID: 2883878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.
    Man in 't Veld AJ; Schalekamp MA
    Br J Clin Pharmacol; 1982; 13(Suppl 2):245S-257S. PubMed ID: 6125175
    [No Abstract]   [Full Text] [Related]  

  • 15. Sympathomimetic amine infusion after beta-adrenoceptor and parasympathetic blockade [proceedings].
    Richards DA; Prichard BN; Hernandez R
    Br J Clin Pharmacol; 1979 Apr; 7(4):429P. PubMed ID: 36120
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship of plasma catecholamines to blood pressure in hypertensive patients during beta-adrenoceptor blockade with and without intrinsic sympathomimetic activity.
    Kirsten R; Heintz B; Böhmer D; Nelson K; Roth S; Welzel D
    Br J Clin Pharmacol; 1982; 13(Suppl 2):397S-406S. PubMed ID: 6125192
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in cardiovascular pharmacology.
    Lucchesi BR
    AANA J; 1974 Oct; 42(5):419-38. PubMed ID: 4155586
    [No Abstract]   [Full Text] [Related]  

  • 18. On the antihypertensive mechanisms of beta-adrenoceptor antagonists in relation to intrinsic sympathomimetic activity, cardioselectivity and hydrophilicity.
    Man in't Veld AJ; Schalekamp MA
    J Pharmacol; 1983; 14 Suppl 2():69-104. PubMed ID: 6138473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs in the treatment of patients with angina pectoris.
    Harry JD
    Bibl Cardiol; 1976; (35):172-82. PubMed ID: 10882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of intrinsic sympathomimetic activity of beta blockers.
    Kostis JB; DeFelice EA; Frishman W; Hosler M; Krieger SK; Aglitz N; Kuo PT
    Angiology; 1981 Nov; 32(11):780-7. PubMed ID: 6119937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.